Who We Are

What We Do

What We Offer

Clinical Development Partnerships

CRT Inc.

Drug Discovery

Biotherapeutic Development

Senior Scientists

Scientific Advisory Board

Case Studies

Pipeline

Strategic Alliances

Agents In Clinical Development

Institutes & Charities

Start-up Companies

2008

2007

Archive

Licensed Products

Company	Product	Development Status	Potential Indications
Merck KGaA & Biomira	Stimuvax®	Phase 3	NSCLC
Oxford BioMedica	Trovax	Phase 3	Colorectal; Renal
AstraZeneca (KuDOS Pharmaceuticals)	Patrin-2	Phase 2	Melanoma; Colorectal
AnorMed & Poniard Pharmaceuticals	Picoplatin	Phase 2	SCLC; Colorectal; Prostate
Onyvax	105AD7	Phase 2	Colorectal; Osteosarcoma
Transgene	MUC1-IL2	Phase 2	Renal; NSCLC; Prostate
Antisoma	AS1404	Phase 2	Ovarian; NSCLC; Prostate
Pfizer	PARP inhibitors	Phase 2	Melanoma
Active Biotech	Superantigen therapy (5T4)	Phase 1	NSCLC
Allos Therapeutics	RH-1	Phase 1	Solid Tumours
Roche & Antisoma	R1550	Phase 1	Breast
Genvax	DNA Vaccine	Phase 1	Lymphoma
Ipsen	Coumate	Phase 1	Breast; Ovarian
Pharminox	Phortress	Phase 1	Solid Tumours
Ipsen & Spirogen	SJG-136	Phase 1	Solid Tumours

Unlicensed Products

Product	Development Status	Potential Indications
HPV Vaccines	Phase 2	Cervical
ADEPT Portfolio	Phase 1	Solid tumours